UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000061626 |
|---|---|
| Receipt number | R000070509 |
| Scientific Title | Effectiveness of Health-Related Information Delivery and Health Status Visualization in the Working Population |
| Date of disclosure of the study information | 2026/06/03 |
| Last modified on | 2026/05/19 11:00:17 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effectiveness of Health Information and Visualization for Workers
Acronym
Effectiveness of Health Information and Visualization for Workers
Scientific Title
Effectiveness of Health-Related Information Delivery and Health Status Visualization in the Working Population
Scientific Title:Acronym
Effectiveness of Health-Related Information Delivery and Health Status Visualization in the Working Population
Region
| Japan |
Condition
Condition
Metabolic syndrome and healthy adults
Classification by specialty
| Medicine in general |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To examine the impact of a series of health awareness activities including health status assessment, information provision, and participatory events on worker's health, awareness, and behavior.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Non-invasive markers of oxidation and glycation
Key secondary outcomes
1.Required Item : Results of periodic health checkups, Grip strength
Health score, Questionnaire (dietary habits, physical activity, sleep, fatigue, skin condition, work motivation, etc.)
2.Optional Items : Sit to stand test, Skin measurements (perceived age, wrinkle analysis), Dorsal hand image analysis (wrinkle analysis)
Dietary records, Step count, Physical activity level, Optimal carbohydrate intake
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Food | Behavior,custom |
Interventions/Control_1
Education, Health score,Interactive event
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 30 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1.Age 30 to 64 at consent, including healthy men and women and those meeting criteria for metabolic syndrome or specified health guidance
2. Able to understand the study purpose and content, voluntarily agree, and provide written informed consent.
Key exclusion criteria
1. Severe allergy risk to specified foods (almond, milk)
2. Pregnant, possibly pregnant, or breastfeeding
3. Implanted or life-support medical devices
4. Unable to attend workplace (serious illness, on leave, remote work only, or medically restricted)
5. Did not undergo 2025 health checkup
6. Not enrolled in Glico Health Insurance (applies only to Glico employees).
Target sample size
600
Research contact person
Name of lead principal investigator
| 1st name | Saito |
| Middle name | |
| Last name | Yasuo |
Organization
Ezaki Glico Co., Ltd
Division name
R&D Laboratory
Zip code
555-8502
Address
4-6-5 Utajima, Nishiyodogawa-ku, Osaka-shi, Osaka
TEL
090-4003-6652
yasuo.saito@glico.com
Public contact
Name of contact person
| 1st name | Hiromi |
| Middle name | |
| Last name | Nishiura |
Organization
Ezaki Glico Co., Ltd
Division name
R&D Laboratory
Zip code
555-8502
Address
4-6-5 Utajima, Nishiyodogawa-ku, Osaka-shi, Osaka
TEL
05017454067
Homepage URL
hiromi.nishiura@glico.com
Sponsor or person
Institute
Ezaki Glico Co., Ltd
Institute
Department
Personal name
Funding Source
Organization
Ezaki Glico Co., Ltd
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
DAIDO LIFE INSURANCE COMPANY
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Institutional Review Board of Glico Group
Address
4-6-5 Utajima, Nishiyodogawa-ku, Osaka-shi, Osaka
Tel
+81-6-6477-8793
dl_rinriiinkai_jimukyoku@glico.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 06 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 02 | Month | 24 | Day |
Date of IRB
| 2026 | Year | 02 | Month | 24 | Day |
Anticipated trial start date
| 2026 | Year | 06 | Month | 05 | Day |
Last follow-up date
| 2027 | Year | 08 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 05 | Month | 19 | Day |
Last modified on
| 2026 | Year | 05 | Month | 19 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070509
